drugset / Trial / NCT06209398
Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine
Phase 4
Unknown
510 enrolled
Jiangsu Province Centers for Disease Control and Prevention
Institute of Medical Biology, Chinese Academy of Medical Sciences · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
The main purpose of this study is to evaluate the immunogenicity and safety of inactivated enterovirus type 71 vaccine combined with recombinant hepatitis B vaccine or Group a meningococcal polysaccharide vaccine.
Timeline
- Start
- 2018-05-24
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Group A meningococcal polysaccharide vaccine | Vaccine | 0.5 ml | Subcutaneous |
| Subject | Menjugate | Vaccine | 0.5 ml | Intramuscular |
| Subject | recombinant hepatitis B vaccine | Vaccine | 0.5 ml | Intramuscular |